Neogen Stock Performance
| NEOG Stock | USD 12.33 0.10 0.80% |
The company secures a Beta (Market Risk) of 2.5, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Neogen will likely underperform. Neogen has an expected return of -0.52%. Please make sure to verify Neogen potential upside, as well as the relationship between the daily balance of power and market facilitation index , to decide if Neogen performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Neogen has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in June 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
Actual Historical Performance (%)
One Day Return (0.80) | Five Day Return 1.57 | Year To Date Return (39.41) | Ten Year Return (14.67) | All Time Return 2.7 K |
Last Split Factor 2:1 | Last Split Date 2021-06-07 |
1 | Q1 2024 Neogen Corp Earnings Call Transcript | 03/06/2024 |
2 | Neogen Q3 Earnings Preview What You Should Know Beyond the Headline Estimates | 04/04/2024 |
3 | Neogen CEO buys 284k worth of company stock | 04/10/2024 |
4 | Neogen Third Quarter 2024 Earnings EPS Misses Expectations | 04/12/2024 |
5 | Insider Trading | 04/15/2024 |
6 | Insider Buying Neogen Corp COO Douglas Jones Acquires 10,000 Shares | 04/17/2024 |
7 | Neogen partners with Performance Food Group for DNA tracing | 04/18/2024 |
8 | Disposition of 563 shares by Amy Rocklin of Neogen at 11.96 subject to Rule 16b-3 | 04/25/2024 |
9 | Acquisition by James Tobin of 3000 shares of Neogen at 15.189 subject to Rule 16b-3 | 04/26/2024 |
10 | Global Animal Health Diagnostics Analysis Report 2024 Market to Grow by Over 2.45 Billion During 2023-2028, Driven by Zoonotic Disease Awareness, Prognosis Adva... | 04/29/2024 |
11 | Neogen Petrifilm Celebrates 40 Years | 05/01/2024 |
12 | Neogen to Participate in the Bank of America 2024 Health Care Conference | 05/08/2024 |
13 | Neogen Faces Macroeconomic Issues, Fierce Competition | 05/10/2024 |
| Begin Period Cash Flow | 44.5 M | |
| Total Cashflows From Investing Activities | 201 M |
Neogen |
Neogen Relative Risk vs. Return Landscape
If you would invest 1,757 in Neogen on February 12, 2024 and sell it today you would lose (524.00) from holding Neogen or give up 29.82% of portfolio value over 90 days. Neogen is currently does not generate positive expected returns and assumes 2.5334% risk (volatility on return distribution) over the 90 days horizon. In different words, 22% of stocks are less volatile than Neogen, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Neogen Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Neogen's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Neogen, and traders can use it to determine the average amount a Neogen's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.2051
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NEOG |
Estimated Market Risk
| 2.53 actual daily | 22 78% of assets are more volatile |
Expected Return
| -0.52 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.21 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Neogen is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neogen by adding Neogen to a well-diversified portfolio.
Neogen Fundamentals Growth
Neogen Stock prices reflect investors' perceptions of the future prospects and financial health of Neogen, and Neogen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Neogen Stock performance.
| Return On Equity | 5.0E-4 | ||||
| Return On Asset | 0.0179 | ||||
| Profit Margin | 0 % | ||||
| Operating Margin | 0.05 % | ||||
| Current Valuation | 3.41 B | ||||
| Shares Outstanding | 216.61 M | ||||
| Price To Earning | 13.36 X | ||||
| Price To Book | 0.85 X | ||||
| Price To Sales | 2.89 X | ||||
| Revenue | 822.45 M | ||||
| Gross Profit | 409.2 M | ||||
| EBITDA | 125.89 M | ||||
| Net Income | (22.87 M) | ||||
| Cash And Equivalents | 347.71 M | ||||
| Cash Per Share | 3.22 X | ||||
| Total Debt | 900 M | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 9.07 X | ||||
| Book Value Per Share | 14.53 X | ||||
| Cash Flow From Operations | 41.03 M | ||||
| Earnings Per Share | 0.02 X | ||||
| Market Capitalization | 2.67 B | ||||
| Total Asset | 4.55 B | ||||
| Retained Earnings | 565.04 M | ||||
| Working Capital | 440.46 M | ||||
| Current Asset | 250 M | ||||
| Current Liabilities | 28.6 M | ||||
About Neogen Performance
To evaluate Neogen Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Neogen generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Neogen Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Neogen market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Neogen's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 134.86 | 202.95 | |
| Return On Tangible Assets | (0.03) | (0.02) | |
| Return On Capital Employed | 0.01 | 0.01 | |
| Return On Assets | (0) | (0) | |
| Return On Equity | (0.01) | (0.01) |
Things to note about Neogen performance evaluation
Checking the ongoing alerts about Neogen for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Neogen help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Neogen generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 822.45 M. Net Loss for the year was (22.87 M) with profit before overhead, payroll, taxes, and interest of 409.2 M. | |
| Over 100.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Neogen Faces Macroeconomic Issues, Fierce Competition |
- Analyzing Neogen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Neogen's stock is overvalued or undervalued compared to its peers.
- Examining Neogen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Neogen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Neogen's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Neogen's stock. These opinions can provide insight into Neogen's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neogen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Neogen Stock analysis
When running Neogen's price analysis, check to measure Neogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neogen is operating at the current time. Most of Neogen's value examination focuses on studying past and present price action to predict the probability of Neogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neogen's price. Additionally, you may evaluate how the addition of Neogen to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
Is Neogen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neogen. If investors know Neogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.86) | Earnings Share 0.02 | Revenue Per Share 4.293 | Quarterly Revenue Growth 0.048 | Return On Assets 0.0179 |
The market value of Neogen is measured differently than its book value, which is the value of Neogen that is recorded on the company's balance sheet. Investors also form their own opinion of Neogen's value that differs from its market value or its book value, called intrinsic value, which is Neogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neogen's market value can be influenced by many factors that don't directly affect Neogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.